TAP regimen
WikiDoc Resources for TAP regimen |
Articles |
---|
Most recent articles on TAP regimen Most cited articles on TAP regimen |
Media |
Powerpoint slides on TAP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on TAP regimen at Clinical Trials.gov Clinical Trials on TAP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on TAP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on TAP regimen Discussion groups on TAP regimen Patient Handouts on TAP regimen Directions to Hospitals Treating TAP regimen Risk calculators and risk factors for TAP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for TAP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Taxol-Anthracycline-Platinol regimen
Overview
TAP regimen refers to a regimen consisting of paclitaxel (Taxol), anthracycline, and cisplatin (Platinol) used to treat endometrial cancer.[1]
Regimen
TPaclitaxel (Taxol)
AAnthracycline
PCisplatin (Platinol)
Indications
References
- ↑ 1.0 1.1 Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR; et al. (2004). "Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study". J Clin Oncol. 22 (11): 2159–66. doi:10.1200/JCO.2004.07.184. PMID 15169803.